Evidence from the RA-BEAM and SELECT-COMPARE trials indicates that certain JAK inhibitors can outperform tumor necrosis factor inhibitors in treating rheumatoid arthritis, a landmark finding that has accelerated the transition from traditional injectable biologics to oral small-molecule therapies.
Because mosunetuzumab targets CD20-positive cells, it is essential for clinicians to confirm the biomarker expression on malignant B cells before initiating the immunotherapy. This diagnostic step ensures that patients with relapsed or refractory follicular lymphoma are appropriate candidates for
The ethical use of healthy, full-term placental tissue provides a unique source of stem-like cells possessing vital immunomodulatory properties for patient safety, and this therapeutic approach has recently gained significant traction as a viable solution for one of the most stubborn challenges in
Recent investigations into clinical isolates have revealed that over half of Pseudomonas aeruginosa strains and three-quarters of Staphylococcus aureus strains exhibit multidrug resistance in hospital settings. This startling reality underscores a burgeoning crisis in modern healthcare, where
A comprehensive meta-analysis of 24 randomized controlled trials indicates that mesenchymal stem cell therapy can reduce the risk of death by 36% in patients suffering from viral lung injury. This revelation comes at a critical time when traditional supportive care often struggles to keep pace with
Patients using the new telehealth portal can have their presbyopia prescriptions processed and shipped directly to their residences following a successful virtual assessment. For many adults over the age of 45, the sudden inability to focus on a restaurant menu or a smartphone screen represents a
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79